Biocon Earnings Call Transcript: Key Takeaways
Q2 FY27 group revenue grew 2% YoY, with about 5% (~$20M) deferred to Q3 by a one-off shipment timing issue. Management guides a stronger H2 but gave no hard H2 numbers.
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
527 announcements with these filters
Q2 FY27 group revenue grew 2% YoY, with about 5% (~$20M) deferred to Q3 by a one-off shipment timing issue. Management guides a stronger H2 but gave no hard H2 numbers.
H1 FY27 PAT ₹868 Cr (+117%) on revenue ₹1,501 Cr (+101%); no guidance given, management declines margin projections.
Second-highest quarterly profit in company history, slightly below Q1; interim dividend held at ₹14.40. No profit figure stated; earnings rest on volatile spot rates.
Maiden call with no reported revenue or PAT figures disclosed. Current sales are minimal cascade volumes (~20,000 cm/day), and value depends on pipeline connectivity due January and March 2027.
Q2 FY27 consolidated revenue ₹1,054.6 Mn (+17.4% YoY); EBITDA ₹95.7 Mn (-47.2%) on monsoon-hit mining. H1 revenue ₹2,380.4 Mn (+27.1%).
H1 FY27 consolidated revenue ₹342.58 Cr (+137%), PAT ₹100.37 Cr (+156%), EBITDA margin 33.5%. FY27 revenue guidance raised to ₹880 Cr+. Growth driven by V2 Retail and Style Baazar FMCG distribution.
H1 FY27 standalone revenue ₹575.7 Mn (+22.4%), EBITDA ₹35.2 Mn (6.1% margin), PAT ₹16.0 Mn vs prior loss; order book ₹506 Mn.
Record Q2 revenue of ₹4,432 Cr (+30% YoY), EBITDA +49% to ₹153 Cr, PAT +44% to ₹70 Cr, net cash ₹154 Cr. Management stays cautious and gives no numeric FY27 revenue guidance.
Q2FY27 revenue Rs2,088.9 Cr (+36% YoY), PAT Rs2.2 Cr vs Rs0.6 Cr, EBITDA margin 3.7%. H1 revenue +39.7%, largely acquisition-led.
Q2 FY27 consolidated revenue ₹67.74 Cr (+45% YoY) and PAT ₹13.21 Cr (+34%). EBITDA margin compressed to 23.60% from 29.22%. Strategy: RegTech, Bank-in-a-Box, international SaaS.
Q2 FY27 revenue ₹4.91bn, down 3.0% YoY; H1 revenue ₹9.34bn, up 6.4%. Record Q2 order booking ₹7.64bn, up 17.2%. Margins under pressure.
H1 FY27 revenue of ₹667 Cr was slightly below ₹680 Cr a year ago. Management blamed a one-month government rate-contract delay and reiterated 25% FY27 growth guidance.
H1FY27 revenue Rs 895 Mn (-57% YoY), PAT Rs 49 Mn (-53%), EBITDA Rs 78 Mn. Deliberate pivot from low-margin product sales to services.
Consolidated Q2 revenue ₹40.09 Cr (+17.9% YoY), PAT ₹9.13 Cr (2.4x YoY), margin 22.8%. Infra consulting carries the growth. PGIPL (40.99% JV) revenue sits outside consolidated revenue, so the headline profit uplift needs scrutiny.
Q2 FY27 consolidated revenue ₹19,886 Cr (+28%), EBITDA ₹4,245 Cr ex one-offs (+13%), PAT before exceptionals ₹1,521 Cr (+46%). Record H1 capex ~₹10,000 Cr; FY30 aspirations unchanged.
Q2 and H1 FY27 revenue grew over 40% YoY to record highs, while EBITDA margin diluted on raw-material inflation. Management withheld numeric guidance; H2 EBITDA is expected to hold versus H1 despite PCB cost risk.
Best-ever Q2: revenue ₹363.8 Cr (+18%), PAT ₹79.8 Cr (+90%), but PAT includes ~₹22 Cr net non-cash exceptional gain; corporate demand still muted.
Q2 FY27 revenue ₹10,294 Cr (+7%), EBITDA ₹944 Cr (-18%), PAT ₹523 Cr (-34%). Margin compression across nutrients; theme 'Consolidate to Accelerate'.
Q2 weak (~₹58 Cr revenue, 14.38% EBITDA margin) on monsoon, maintenance and diesel costs. H1 revenue up 16.3% on a record ₹767 Cr order book. Management repeats its FY27 15-20% growth target with hedging and deflects promoter stake-sale questions.
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
Strong H1 FY27: income ₹616 Cr (+35%), PAT ₹169 Cr (+35%), FPAUM ₹49,164 Cr. Infra Fund One exit flatters Q1 earnings, and fee growth trails AUM growth.
Q2 FY27 revenue excluding fair value changes ₹7.56 Cr (+18.7% YoY). H1 ₹14.30 Cr (+20.2%). Reported PAT loss of ₹35.83 Cr in Q2 due to treasury fair value losses. Demerger pending NCLT.
Consolidated revenue rose 31% to ₹118 Cr; PAT ₹20–21 Cr (CEO and CFO figures differ). EBITDA margin eased to 23.3% from 24% YoY, partly from JV consolidation. Order book ₹2,000 Cr. Management's Q3–Q4 ramp claims are unquantified.
H1 FY27 revenue ₹106.5 Cr (+153.5% YoY), PAT ₹15.3 Cr (+159.4%), EBITDA margin 23.6%. Demand strong; supply and working capital are the constraints.
H1 FY27 revenue +24%, PAT ~+17%, but operating cash flow turned negative on receivables, inventory and early payables. Quartz hit 16k tons in Q2 and is still ramping. Management is confident on targets; its cash-flow explanation is defensive.
Q2 revenue rose 29.8% to ₹177.8 Cr, but gross margin fell to 39.8% from 45.6% on raw material costs and mix. EBITDA margin was 8.8%. PAT of ₹2.5 Cr followed a prior-year loss.
Q2 FY27 revenue INR 1,200 Mn (+82.1% YoY), EBITDA margin 7.83%, PAT INR 61 Mn (-26.5%). H1 revenue INR 1,961 Mn (+62.3%), PAT INR 107 Mn. Order book INR 11,207 Mn, BESS-led.
Q2 PAT of ₹0.9 Cr (+229% YoY) comes off a tiny base. Disbursements rose 14% QoQ to ₹87 Cr, but AUM sits near ₹800 Cr, and growth depends on H2 disbursements of ₹500-600 Cr.
Q2 FY27 revenue INR75.6 Cr (-5% YoY), PAT INR7.1 Cr (vs 12.8). H1 revenue +11.4% to INR113.1 Cr, PAT +43.2% to INR19.9 Cr. Strategy: SME IPO core, mainboard expansion, recurring advisory.
Q2 FY27 revenue ₹860 Cr, up 15% QoQ but down ~31% YoY on weak Indian Railway orders. EBITDA margin 10.2% (vs 10.8%). A ₹76 Cr exceptional JV gain props up profit, and answers on the ₹700 Cr provision were evasive.